Knight Therapeutics buy krebskrebs
Start price
30.11.20
/
50%
€3.50
Target price
30.11.21
€4.00
Performance (%)
5.14%
End price
01.12.21
€3.68
Summary
This prediction ended on 01.12.21 with a price of €3.68. With a performance of 5.14%, the BUY prediction by krebskrebs for Knight Therapeutics closed with a slight gain. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Knight Therapeutics | -3.960% | -3.960% | 13.450% | 9.605% |
iShares Core DAX® | -0.284% | -1.519% | 15.326% | 16.634% |
iShares Nasdaq 100 | 3.902% | 5.242% | 31.471% | 56.359% |
iShares Nikkei 225® | 2.335% | 1.663% | 7.422% | 6.486% |
iShares S&P 500 | 2.818% | 2.879% | 25.986% | 48.637% |
Comments by krebskrebs for this prediction
In the thread Knight Therapeutics diskutieren
Buy mit Kursziel 4,0
In the thread Trading Knight Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten